azulfidine en tablets 500mg (アザルフィジンen錠500mg)
ayumi pharmaceutical co., ltd. - salazosulfapyridine - yellow to yellowish brown tablet, major axis: 18.0mm, minor axis: 9.5mm
salazopyrin suppositories 500mg (サラゾピリン坐剤500mg)
pfizer pharmaceuticals inc. - salazosulfapyridine - yellowish brown to brownish-red spindle-shaped suppository, diameter: 8 to 11 mm, length: 30 mm
salazopyrin tablets 500mg (サラゾピリン錠500mg)
pfizer pharmaceuticals inc. - salazosulfapyridine - yellow to yellowish brown oval tablet with split line, diameter: 17.7 × 7.5 mm, thickness: 5.7 mm
foot rot boluses tablet
professional veterinary laboratories - sulfapyridine; ethylenediamine dihydroiodide - tablet - 13g; 400mg - sulfapyridine 13g; ethylenediamine dihydroiodide 400mg - cattle
trisulfa g liq liquid
norden laboratories inc. - sulfapyridine; sulfamethazine; sulfathiazole - liquid - 20mg; 45mg; 45mg - sulfapyridine 20mg; sulfamethazine 45mg; sulfathiazole 45mg - cattle; horses; sheep; swine (pigs)
concord 693 250mg capsules
evolan pharma ab - sulfapyridine - oral capsule - 250mg
sulfasalazine tablet
aphena pharma solutions - tennessee, llc - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine tablets are indicated: - in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; and - for the prolongation of the remission period between acute attacks of ulcerative colitis. sulfasalazine tablets are contraindicated in: patients with intestinal or urinary obstruction, patients with porphyria as sulfonamides have been reported to precipitate an acute attack, patients hypersensitive to sulfasalazine, its metabolites, sulfonamides or salicylates. none reported.
sulfasalazine tablet
major pharmaceuticals - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine 500 mg
sulfasalazine tablet
greenstone llc - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine 500 mg - sulfasalazine tablets are indicated: sulfasalazine tablets are contraindicated in: none reported.
sulfasalazine delayed-release tablet
qualitest pharmaceuticals - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine 500 mg